Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,037 | 84,057 | 76,677 | 82,978 | 91,276 |
| TOTAL | $87,068 | $85,373 | $78,263 | $85,596 | $95,537 |
| Non-Current Assets | |||||
| PPE Net | 460 | 496 | 550 | 601 | 624 |
| Other Non-Current Assets | 2,333 | 2,483 | 2,632 | 2,747 | 2,890 |
| TOTAL | $2,793 | $2,979 | $3,182 | $3,348 | $3,514 |
| Total Assets | $89,861 | $88,352 | $81,445 | $88,944 | $99,051 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,177 | 7,513 | 7,953 | 8,150 | 8,637 |
| TOTAL | $9,728 | $8,064 | $8,494 | $8,672 | $9,151 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,284 | 1,414 | 1,553 | 1,689 | 1,823 |
| TOTAL | $36,298 | $36,431 | $36,572 | $36,689 | $36,823 |
| Total Liabilities | $46,026 | $44,495 | $45,066 | $45,361 | $45,974 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,154 | 29,783 | 29,396 | 27,413 | 26,998 |
| Common Shares | 31 | 29 | 28 | 27 | 27 |
| Retained earnings | -357,606 | -346,253 | -337,583 | -328,259 | -314,983 |
| TOTAL | $43,835 | $43,857 | $36,379 | $43,583 | $53,077 |
| Total Liabilities And Equity | $89,861 | $88,352 | $81,445 | $88,944 | $99,051 |